Literature DB >> 10386889

Simple synthesis of sialyllactose-carrying polystyrene and its binding with influenza virus.

A Tsuchida1, K Kobayashi, N Matsubara, T Muramatsu, T Suzuki, Y Suzuki.   

Abstract

Glycoconjugate polystyrenes bearing sialyllactose moieties were prepared via a simple method from a mixture of alpha2-6 and a2-3 linked sialyllactose isomers of bovine milk origin. The reducing end of sialyllactose was converted to an amino function with ammonium hydrogen carbonate and then coupled with p-vinylbenzoyl chloride. The resulting styrene derivative substituted with sialyllactose via an amide linkage was polymerized with ammonium peroxodisulfate and N,N,N',N-tetramethylethylenediamine in water at 30 degrees C. The interaction of the glycopolymer with influenza A and B viruses was investigated by three different methods. The glycopolymer inhibited the hemagglutination of influenza A virus (PR/8/34) and its activity was 10(3) times higher than that of the oligosaccharide itself. The cytopathic effect of virus-infected MDCK (Madine-Darby canine kidney) cells was inhibited by the glycopolymer. The homopolymer showed 10(2) times higher inhibitory activity than naturally-occurring fetuin. It was also found that various viruses could be trapped by the glycopolymer adsorbed on a polystyrene surface. The inhibitory and trapping activities of the glycopolymers were correlated with the sialyl linkage specificities of the virus strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10386889     DOI: 10.1023/a:1006960116583

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  21 in total

1.  Carbohydrate materials bearing neuraminidase-resistant C-glycosides of sialic acid strongly inhibit the in vitro infectivity of influenza virus.

Authors:  J O Nagy; P Wang; J H Gilbert; M E Schaefer; T G Hill; M R Callstrom; M D Bednarski
Journal:  J Med Chem       Date:  1992-11-13       Impact factor: 7.446

Review 2.  Selectins: interpreters of cell-specific carbohydrate information during inflammation.

Authors:  L A Lasky
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

3.  Inhibition of influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates.

Authors:  A Gamian; M Chomik; C A Laferrière; R Roy
Journal:  Can J Microbiol       Date:  1991-03       Impact factor: 2.419

4.  Synthesis of artificial glycoconjugate polymers starting from enzymatically synthesized oligosaccharides and their interactions with lectins.

Authors:  A Tsuchida; S Akimoto; T Usui; K Kobayashi
Journal:  J Biochem       Date:  1998-04       Impact factor: 3.387

5.  Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection.

Authors:  T Suzuki; A Sometani; Y Yamazaki; G Horiike; Y Mizutani; H Masuda; M Yamada; H Tahara; G Xu; D Miyamoto; N Oku; S Okada; M Kiso; A Hasegawa; T Ito; Y Kawaoka; Y Suzuki
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  A 'litmus test' for molecular recognition using artificial membranes.

Authors:  D Charych; Q Cheng; A Reichert; G Kuziemko; M Stroh; J O Nagy; W Spevak; R C Stevens
Journal:  Chem Biol       Date:  1996-02

Review 7.  Gangliosides as influenza virus receptors. Variation of influenza viruses and their recognition of the receptor sialo-sugar chains.

Authors:  Y Suzuki
Journal:  Prog Lipid Res       Date:  1994       Impact factor: 16.195

8.  N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid.

Authors:  Y Suzuki; M Matsunaga; M Matsumoto
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  Neuraminidase-resistant hemagglutination inhibitors: acrylamide copolymers containing a C-glycoside of N-acetylneuraminic acid.

Authors:  M A Sparks; K W Williams; G M Whitesides
Journal:  J Med Chem       Date:  1993-03-19       Impact factor: 7.446

10.  Chemoenzymic preparation of a glycoconjugate polymer having a sialyloligosaccharide: Neu5Ac alpha (2-->3)Gal beta (1-->4)GlcNAc.

Authors:  S Nishimura; K B Lee; K Matsuoka; Y C Lee
Journal:  Biochem Biophys Res Commun       Date:  1994-02-28       Impact factor: 3.575

View more
  7 in total

1.  NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.

Authors:  Michal Mendelson; Yoram Tekoah; Alon Zilka; Orly Gershoni-Yahalom; Roi Gazit; Hagit Achdout; Nicolai V Bovin; Tal Meningher; Michal Mandelboim; Ofer Mandelboim; Ayelet David; Angel Porgador
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

2.  A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.

Authors:  Rameshwar U Kadam; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

3.  Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation.

Authors:  Yi-Shin Pan; Hung-Ju Wei; Chung-Chieh Chang; Chung-Hung Lin; Ting-Shyang Wei; Suh-Chin Wu; Ding-Kwo Chang
Journal:  J Biomed Biotechnol       Date:  2010-12-09

Review 4.  Marine bacterial sialyltransferases.

Authors:  Takeshi Yamamoto
Journal:  Mar Drugs       Date:  2010-11-05       Impact factor: 5.118

5.  Carbohydrate-Based Polymers for Immune Modulation.

Authors:  Kenneth Lin; Andrea M Kasko
Journal:  ACS Macro Lett       Date:  2014-06-17       Impact factor: 6.903

6.  Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus.

Authors:  Lutz Adam; Eva Müller; Kai Ludwig; Simon Klenk; Daniel Lauster; Susanne Liese; Andreas Herrmann; Christian P R Hackenberger
Journal:  Bioconjug Chem       Date:  2022-06-27       Impact factor: 6.069

Review 7.  Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.

Authors:  Aarthi Narayanan; Charles Bailey; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.498

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.